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Bronchiolitis obliterans usually follows severe lower respiratory tract infection and is a
rare complication in children. We present a case of an adolescent who presented in an
insidious manner following Mycoplasma pneumoniae infection. Further investigations
demonstrated co-infection with adenovirus. Attempts at medical treatment made no
difference and she was left with severely reduced lung function (FEV1 23% predicted). She
is likely to require lung transplantation at some stage, although the timing and risks of
transplantation need careful consideration.
Crown Copyright & 2008 Published by Elsevier Ltd. All rights reserved.Introduction
Bronchiolitis obliterans (BO) is a chronic, obstructive lung
disease characterized by small airways obstruction and ﬁxed
bronchoconstriction. The pathological features are inﬂam-
mation and ﬁbrosis of the terminal and respiratory bronch-
ioles that lead to narrowing or complete obliteration of the
airway lumen. It is an infrequent, but distinctive reaction of
the small airways to infectious, toxic and immunologic
insults.Copyright & 2008 Published by El
345 5844;
g.au (A. Tai).In children, bronchiolitis obliterans occurs most com-
monly following an acute severe lower respiratory tract
infection. Causative organisms include adenovirus,1–5 inﬂu-
enza6 and rarely mycoplasma.2,7–9 The association with
mycoplasma is curious as it is one of the commonest causes
of community-acquired pneumonia in children, yet long-
term pulmonary sequelae are rare.
Bronchiolitis obliterans also occurs following Stevens–
Johnson syndrome,10 after allogenic bone marrow trans-
plantation as manifestation of graft-versus-host-disease,
and after heart–lung or lung transplantation as organ
rejection.11
Clinically, patients with bronchiolitis obliterans present
with shortness of breath of varying severity. Findings on
chest imaging may include a number of abnormalitiessevier Ltd. All rights reserved.
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Figure 1 Axial and coronal slice CT chest images demonstrat-
ing markedly hyperinﬂated lungs with bilateral scattered areas
of mosaic attenuation and decreased caliber of pulmonary
vasculature.
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patterns, areas of vascular attenuation, atelectasis and
bronchiectasis.12,13 Patients demonstrate severe obstructive
lung disease on lung function testing with no or minimal
bronchodilator response.
We present a case of bronchiolitis obliterans in an
adolescent presenting with a relatively insidious course
following an initially proven mycoplasma infection but
subsequent testing revealed co-infection with adenovirus.
Case report
A previously healthy 14-year-old girl presented to her local
doctor with fever, dry cough and lethargy for 2 weeks.
A chest X-ray showed left lingular and left lower lobe
consolidation. She was commenced on a 2-week course of
roxithromycin. Her fevers resolved over 1 week, but she had
a persistent dry cough and developed shortness of breath
and could only walk short distances, leaving her house-
bound. She was reviewed by her family doctor 4 weeks later
at which time a repeat chest X-ray was unchanged. There
was no history of asthma, allergies, recurrent infections,
toxic exposures or recent travel. Mycoplasma was conﬁrmed
on serum enzyme immunoassay testing.
Eight weeks after the onset of symptoms and with no
recovery, she was referred to our institution for assessment.
She mobilized in a wheel chair due to respiratory limitation.
She was obese (BMI 32). She was afebrile with a respiratory
rate of 30 breaths per minute and mild increased work of
breathing. There was no digital clubbing and she was not
hyperinﬂated. She had reduced air entry in both lungs with
diffuse soft wheeze. There was no clinical evidence of
pulmonary hypertension. There was no rash or joint
discomfort. Oxyhemoglobin saturation in room air was 92%.
At initial assessment her spirometry demonstrated sig-
niﬁcant obstructive airways disease with marked airway
trapping (see Table 1). Exercise oximetry revealed oxyhe-
moglobin desaturations into the 80s within 2min of walking.
Overnight oximetry demonstrated desaturations into the
high 80s when asleep. The patient was started on 0.5 liters/
min supplemental oxygen while asleep.
A high resolution, volumetric CT chest demonstrated
markedly hyperinﬂated lungs, bilateral areas of mosaic
attenuation, decreased caliber of pulmonary vessels and air
trapping. These changes were consistent with bronchiolitis
obliterans. There was no bronchiectasis (see Figure 1).Table 1 Results of baseline spirometry, post-bronchodilator and 4 weeks following treatment with prednisolone and
azithromycin.
Baseline Post-bronchodilator (at baseline) 4 weeks later
FVC liters/s (% predicted) 1.12 (27%) 1.33 (32%) 2.16 (55%)
FEV1 liters/s (% predicted) 0.72 (21%) 0.75 (21%) 0.82 (24%)
FEF25–75% liters/s (% predicted) 0.31 (7%) 0.38 (9%) 0.3 (7%)
TLC liters (% predicted) 7.14 (139%) 7.18 (141%)
RV liters (% predicted) 4.44 (393%) 4.46 (398%)
RV/TLC ratio 62% 62%
Apparently improved FVC is likely to represent better lung function technique given the absence of improvement in lung volumes.
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further investigations that included: sweat chloride, im-
munoglobulins and IgG subclasses, T-cell subsets and
function, antibody responses to pertussis, tetanus and
pneumococcal vaccines which were all normal. Adenoviral
IgG (titers 1: 5120) was elevated when compared to
measurement on her early blood test (adenoviral titers 1:
128) suggesting recent infection to adenovirus. Serology to
inﬂuenza, respiratory syncytial virus and parainﬂuenzae
viruses were not elevated. Cardiac echocardiogram demon-
strated a structurally normal heart and no evidence of
pulmonary hypertension.
She was treated with a 4-week course of prednisolone
(50mg daily) and azithromycin (500mg daily). At the end of
the treatment, she remained signiﬁcantly breathless with
limitation in her activities of daily living. Repeat spirometry
demonstrated no improvement (see Table 1). She was
subsequently weaned from prednisolone and azithromycin.
Given her poor quality of life, she was referred for
psychological counseling and review by a rehabilitation
physician. She has been immunized with inﬂuenza and
pneumococcal vaccine. The family was keen to pursue
discussions about lung transplantation.Discussion
Bronchiolitis obliterans in children most commonly follows
severe lower respiratory tract infections. It is more common
in infants (but not those o6 months) and young chil-
dren.5,14,15 The course of patients with bronchiolitis
obliterans varies from mild, asthma-like symptoms to
rapidly progressive deterioration and death. There are three
points to highlight in this case. Firstly, mycoplasma is a rare
cause of bronchiolitis obliterans and co-infection with
adenovirus should always be suspected. Secondly, the
insidious manner of presentation is unusual and therefore
subjects with unexplained shortness of breath following
respiratory tract infections should be referred to respiratory
care as soon as possible. Thirdly, bronchiolitis obliterans
following lower respiratory tract infection is not restricted
to infants and children, but can also occur to adolescents.
We reviewed the medical literature (Medline 1966–2007)
and found scattered case reports of bronchiolitis obliterans
following mycoplasma infection.7,8 Chan et al. (2000) reported
three cases of brochiolitis olbiterans attributed to mycoplasma
infection (based on a two-fold increase in paired serological
titers), but there was no mention of adenoviral co-infection.15
In a larger series of bronchiolitis obliterans by Kim et al. (2001),
two subjects were included who had co-infection with both
mycoplasma and adenovirus.2 We have previously reported a
case of bronchiolitis obliterans thought to be caused by
respiratory syncytial virus, but re-examination of available
serum implicated adenovirus.16 Not all adenovirus infections
result in bronchiolitis obliterans, but serotypes 3, 7 and 21 are
thought to be the principal sub-types.3,17,18 While we were not
able to serotype the adenovirus in our case, identiﬁcation of
adenovirus facilitated the diagnosis in this unusual presentation.
The other features of our case that were typical of
bronchiolitis obliterans were the ﬁxed airways obstruction
and the high-resolution CT appearances. This was important
to us as it avoided the need for lung biopsy.12,13The treatment of bronchiolitis obliterans remains un-
satisfactory. The use of corticosteroids in the early phase of
the illness may be beneﬁcial in modifying the inﬂammatory
cascade.2 In our patient, the use of high dose prednisolone
for 4 weeks was commenced well beyond the acute phase of
the illness and made no clinical or lung function improve-
ment. The use of bronchodilators are common among
patients with bronchiolitis obliterans, but of no value in
patients with ﬁxed airway obstruction.2 The use of macro-
lides are unproven in this case, despite the literature
suggesting some beneﬁt post-lung transplant. Their effect
post-transplant may be due to infection with atypical
organisms or a non-speciﬁc anti-inﬂammatory effect.19 By
the time we saw this patient, it is likely any active airway
inﬂammation had evolved to ﬁbrosis.
The development of pediatric lung transplantation has
given some children with end-stage lung disease, including
bronchiolitis obliterans, an opportunity for improved quality
of life and survival. From January 1991 to June 2006, the
international registry for heart and lung transplantation lists
only 35 children with bronchiolitis obliterans who have been
transplanted (3.6% of total pediatric lung transplants).20
There are no survival ﬁgures individualized to bronchiolitis
obliterans. Of some concern, perhaps theoretical, is the risk
of bronchiolitis obliterans being more likely to happen in the
transplanted lung if the original diagnosis was also bronch-
iolitis obliterans. The adolescent we presented was keen to
explore the possibility of lung transplantation to improve
her quality of life. The difﬁculty we have recommending this
treatment is the fact that her pulmonary function may
remain the same for many years. It may not be until she
reaches 25 years of age, another 10 years, that her lung
function starts to decline. While the average yearly decline
of FEV1 from 25 years of age is around 25ml/year for
women, it could be faster in her.21 We have recommended
weight loss as a way of improving the balance of her
metabolic requirement and poor lung function along with a
pulmonary rehabilitation program. Advice regarding avoid-
ance of active smoking was given and assistance to quit
smoking offered to her mother.
In conclusion, we have presented a case of an adolescent
with bronchiolitis obliterans secondary to concurrent myco-
plasma and adenovirus infection. This case is unusual
because of its insidious presentation and the age group of
the patient. We recommend further testing to identify
adenovirus in all cases of post-infectious bronchiolitis
obliterans. This case highlights the lack of effective
interventions for the treatment of bronchiolitis obliterans
and the difﬁcult decisions around lung transplantation for
this condition.
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